CSAM Health Group AS
CSAMF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5% | 1,110.9% | -90.9% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 93.7% | 92.1% | 29.2% | 92.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | -$0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Income | $0 | -$0 | $0 | -$0 |
| % Margin | 9.1% | -6.5% | 34.9% | -3.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$0 | $0 | -$0 |
| Tax Expense | -$0 | $0 | -$0 | -$0 |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 6.5% | -28% | 9.8% | -22.7% |
| EPS | 0.39 | -1.6 | 0.046 | -1.16 |
| % Growth | 124.4% | -3,563.2% | 104% | – |
| EPS Diluted | 0.39 | -1.6 | 0.046 | -1.16 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$0 | $0 | -$0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 30.8% | -1.3% | 21.9% | 4% |